Summary
The levels of transaminases in the C.S.F. and the serum in forty cases of various neurological disorders were determined. In most of the cases of tuber-culous meningitis the C.S.F. levels of transaminases showed an increase corresponding to the rise in proteins and cell count. High levels were noted in cases with more severe involvement of the disease with multiple neurological deficit. Some of the cases of epilepsy showed increased contents of serum transaminases. In other cases of neurological disorders the values of C.S.F. and serum transaminases were within the normal limits or showed only a borderline elevation. It is apparent that the estimation of these enzymes in neurological disorders does not have any diagnostic value. It may, however, be possible to correlate the raised transaminase levels with brain damage and thus help to prognosticate the development of sequelae such as paralysis of the extremities and cranial nerves, spinal blocks, cerebral palsy, mental retardation, etc.
Similar content being viewed by others
References
Aronson, S.M. (1960). Enzyme determination in neurologic and neuromuscular disorders of infancy and childhood.Pediat. Clin. N. Amer. 7, 527.
Fleisher, G.A., Wakim, K.G. and Goldstein, N.P. (1957). Glutamic oxalacetic transaminase and lactodehydrogenase in serum and C.S.F. of patients with neurological disorders.Proc. Staff. Meet. Mayo Clin. 32, 188.
Green, J.B., Oldeworiel, H., O’Doherty, D.S., Foreste, F.M. and Sanchez Longo, L.P. (1957). Cerebrospinal fluid glutamic oxaloacetic transaminase activity in neurologic diseases.Neurology,7, 313.
Katzman, R., Fishman, R.A. and Goldewsohn, E.S. (1957). Glutamic oxaloacetic transaminase activity in spinal fluid.Neurology,7, 853.
Lending, M. Slobody, L.B., and Mestern, J. (1959). Effect of convulsions on C.S.F. and plasma activity of glutamic oxaloacetic transaminase and lactodehydrogenase.Neurology,9, 672.
Miyazaki, M. (1958). Glutamic oxaloacetic transaminase in C.S.F.J. Nerve. & Ment. Dis. 126, 169.
Myerson, R.M., Hurwitz, J.K. and Sall, T. (1957). Serum and C.S.F. transaminase in various neurologic disorders.New Engl. J. Med. 257, 273.
Siekert, R.G., Gerard, E.A., and Fleisher, G.A. (1956). Serum G.O.T. in certain neurologic and neuromuscular diseases.Proc. Staff Meet. Mayo Clinic,31, 459.
Umbreit, W.W., Rahway, V.J., Kingsley, G.R., Schaffert, R.R. and Siblet, H. (1957). A colorimeteric method for transaminases in serum or plasma.J. Lab. Clin. Med. 49, 454.
Author information
Authors and Affiliations
Additional information
From the Department of Pediatrics, M.G.M. Medical College, Indore (M.P.).
Rights and permissions
About this article
Cite this article
Srivastava, G. Serum and C.S.F. levels of transaminases in neurological disorders. Indian J Pediatr 38, 27–31 (1971). https://doi.org/10.1007/BF02787646
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02787646